Ameritas Investment Partners’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.9K | Hold |
4,184
| – | – | ﹤0.01% | 2691 |
|
|
2025
Q1 | $19.4K | Hold |
4,184
| – | – | ﹤0.01% | 2570 |
|
|
2024
Q4 | $29K | Hold |
4,184
| – | – | ﹤0.01% | 2472 |
|
|
2024
Q3 | $22.2K | Buy |
4,184
+1,943
| +87% | +$10.3K | ﹤0.01% | 2597 |
|
|
2024
Q2 | $8.38K | Hold |
2,241
| – | – | ﹤0.01% | 2974 |
|
|
2024
Q1 | $15.8K | Hold |
2,241
| – | – | ﹤0.01% | 2661 |
|
|
2023
Q4 | $12.7K | Hold |
2,241
| – | – | ﹤0.01% | 2766 |
|
|
2023
Q3 | $10.7K | Hold |
2,241
| – | – | ﹤0.01% | 2817 |
|
|
2023
Q2 | $15.4K | Hold |
2,241
| – | – | ﹤0.01% | 2703 |
|
|
2023
Q1 | $17.5K | Hold |
2,241
| – | – | ﹤0.01% | 2521 |
|
|
2022
Q4 | $16K | Hold |
2,241
| – | – | ﹤0.01% | 2650 |
|
|
2022
Q3 | $18K | Hold |
2,241
| – | – | ﹤0.01% | 2568 |
|
|
2022
Q2 | $21K | Hold |
2,241
| – | – | ﹤0.01% | 2527 |
|
|
2022
Q1 | $31K | Buy |
2,241
+1,354
| +153% | +$18.7K | ﹤0.01% | 2340 |
|
|
2021
Q4 | $18K | Hold |
887
| – | – | ﹤0.01% | 2686 |
|
|
2021
Q3 | $20K | Buy |
+887
| New | +$20K | ﹤0.01% | 2696 |
|